A Study of PRT811 in Participants With Advanced Solid Tumors, CNS Lymphoma and Gliomas

NCT04089449 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

86

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Solid Tumor
Recurrent Glioma

Interventions

DRUG: PRT811

Sponsor

Prelude Therapeutics